Medicines and Medical Devices Bill

Sharon Hodgson Excerpts

2nd reading & 2nd reading: House of Commons & Money resolution & Money resolution: House of Commons & Programme motion & Programme motion: House of Commons & Ways and Means resolution & Ways and Means resolution: House of Commons
Monday 2nd March 2020 Commons Chamber

[Mrs Sharon Hodgson (Washington and Sunderland West) (Lab)]

This has been an excellent debate—and we seem to have plenty of time left for winding up. I thank all Members from all parties who have taken part, and particularly my hon. Friends for their excellent speeches: my hon. Friend the Member for Blaydon (Liz Twist) made the case for Kuvan for sufferers of PKU, which I shall mention again in a moment, and my hon. Friend the Member for St Helens South and Whiston (Ms Rimmer) made a powerful speech about organ harvesting that I am sure we will discuss in more detail in Committee.

The hon. Member for Bosworth (Dr Evans) raised an issue that is not currently on the face of the Bill but perhaps should be. It is something that I have discussed with Health Secretaries for well over a decade now—probably around 12 years—starting with the then Member for Kingston upon Hull West and Hessle when Labour was in government, and I raised it with the Minister only last week. The issue is the waste of prescription medication. The hon. Gentleman mentioned a possible figure of £300 million a year from the House of Commons Library, and that did not surprise me. I can well believe that that could be the figure and agree that there has to be a way to reduce that waste. As the hon. Gentleman said, we should start by measuring it, and perhaps consider the active, safe charitable donation of such medicines, because £300 million-worth of perfectly good medicines being put into an incinerator every year cannot be the best outcome. There has to be a better way. I am grateful to the hon. Gentleman for raising that issue, which the Minister will remember we discussed just last week.

I thank the Minister and her officials, who have taken the time last week and since to brief me and my team on the Bill. As my hon. Friend the Member for Leicester South (Jonathan Ashworth) said in his opening remarks, the Opposition support the principle of the Bill, but we have some concerns that I shall briefly outline and to which I hope the Minister will respond, if not now then perhaps at a later stage in the Bill’s progress through the House. The Bill deals with both human and animal health, and I shall start with human health.

Patient safety is of the utmost importance and I recognise that with the Bill the Government are taking steps to improve both patient safety and the availability of medicines and medical devices to patients in the UK after the transition period is over on 31 December this year. However, as the Minister knows, in the cases of valproate, Primodos and surgical mesh, which we have heard about already in the debate, patient safety and patients’ experiences in the past—sometimes even now, in respect of mesh—have sometimes been disregarded when they have reported issues to their GP. The independent medicines and medical devices safety review has been looking into that, and I very much look forward to seeing Baroness Cumberlege’s recommendations later this month.

I should also mention that there are questions of patient safety in respect of other devices, such as breast implants and metal-on-metal hip implants. There are a host of examples of patient safety having been compromised. We must ensure that that does not happen again.

Medical devices are not subject to the same strict regulations as medicines. Faulty washing machines are treated with far more caution than a medical device that goes wrong. A case in point is that we will all have been written to recently by Whirlpool. Regulations must be tightened for both medicines and medical devices. I am sure that the Government will consider seriously the forthcoming recommendations from Baroness Cumberlege in the review.

One mechanism in the Bill to increase patient safety is the provision to establish a database for medical devices and provide the Secretary of State with new powers to share information about medical devices in limited circumstances. However, there are approximately 80,000 different medical devices on the UK market. Will every device be entered into the database? What steps have been taken to establish such a database? Will the Minister please provide some more information about the point at which the Secretary of State will be mandated to share the information held on a medical device with the public? I wholeheartedly agree that there should be a database of this nature, but it must be fit for purpose and healthcare professionals must be able to access an updated database to make sure that they can provide the best treatment and care for their patients that is safe. I hope that the database would go further and become a register or even a registry, as the hon. Member for Central Ayrshire (Dr Whitford) suggested. A barcode could be included on each device that is scanned into a patient’s records so that a register or registry is created.

As I have mentioned, the Bill makes provisions for access to medicines and medical devices after 31 December. However, it is causing concern for some patients who are currently participating in EU-wide clinical trials and for patients who fear that they may miss out on future trials. Can the Minister provide any assurances today about access to EU-wide clinical trials, especially for those patients who are already on them? Access to such clinical trials would especially benefit patients with rare diseases, who have a small patient group here in the UK. Will the Minister please set out what provisions will be made for patients with rare diseases who could benefit from participating in a clinical trial?

As this Bill comes into force on 1 January 2021, will the Minister reassure the House that the supply of medicines and medical devices will be maintained in the run-up to the end of the transition period? This Bill could enhance access to medicines, but what does that mean for patients with rare diseases? For example, as we heard from my hon. Friend the Member for Blaydon, who spoke so passionately about PKU, patients have been waiting for more than 10 years for the drug, Kuvan, to be made available on the NHS. We know that Kuvan works for patients with PKU, because some have raised funds for it and been paying for it privately. Although it is expensive, the cost is not outwith the reach of some patients, but patients in the UK should not have to go without effective drugs. I am sure that we have all had constituents who have brought these cases to us. I therefore hope that provisions will be made to improve access to medicines, particularly for those people with rare diseases.

I welcome the Government’s announcement today about faster access to cannabis-based medicines, and I would be very grateful if the Minister could please expand on that announcement and how that relates to this Bill in particular. I also welcome the provisions in the Bill that allow for prescription powers to be granted to some bodies within the healthcare system—for example, to physiotherapists. Will the Minister set out what she envisages this system will look like, who will be able to prescribe, and what they will be able to prescribe and under what circumstances? Will these new prescribers be trained sufficiently to fulfil this role? Where will they get their information from about medicines and medical devices that they are prescribing, especially if there are new warnings on them, as we have seen, for instance, with Valproate.

The Bill also allows for pharmacy hubs to be established under a Henry VIII power, so will the Minister give the House a timescale for this power to be used? I would also be grateful if she outlined how these pharmacy hubs will work in practice, as I am concerned that this could open up an Amazon-style prescription service.

Let me move on to animal health and veterinary medicine. Although this subject is more likely to come under a DEFRA brief, I know that there is a link between human health and animal health, not least when it comes to antimicrobial resistance. Keeping our animals fit and healthy and ensuring that vets have the medicines that they need to provide treatment and care for animals is, of course, crucially important to many of us. Will the Minister please assure the House that the supply of veterinary medicines in the UK will be maintained in the run-up to the end of the transition period and that standards for veterinary medicines will be upheld to ensure that animals are given the best possible treatment after the transition period.

The Bill gives powers to relevant bodies to amend regulations as necessary, so will the Minister assure the House that the regulators are equipped with the right finance and resources to take on these new responsibilities? I am pleased that, in non-urgent cases, there will be consultations held before any regulations are changed, but can the Minister outline how long these consultations will run for and how soon after the consultation closes the new regulation will be implemented? What formal processes will be put in place to ensure that industry is involved in these consultations and, finally, how will the Government monitor the effectiveness of the regulations? What bodies will be able to scrutinise the performance and delivery of the regulators?

As I mentioned at the beginning of my speech, we do not want to find ourselves in several years’ time with news that a medical device or medicine is causing serious harm to patients—more than we have already, given what Baroness Cumberlege is looking into. Regulators must be held to account on this as much as the manufacturing industry and healthcare system.

In closing, human and animal safety is of the utmost importance, which is why we on the Labour Benches welcome this Bill, but I would be grateful if the Minister could answer these questions. If that is not possible in the time available tonight, especially given the rate at which I have put these questions to her, then perhaps in writing or indeed, during the passage of the Bill in Committee.

Acquired Brain Injury

Sharon Hodgson Excerpts

Thursday 6th February 2020 Westminster Hall

[Mrs Sharon Hodgson (Washington and Sunderland West) (Lab)]

It is a pleasure to serve under your chairmanship this afternoon, Mr Robertson.

I begin by congratulating my hon. Friend the Member for Rhondda (Chris Bryant) on securing this very important debate, on his excellent speech, and on his continuing honesty and willingness to share details of his personal experience, in order to further the vital campaigning on acquired brain injuries.

I also thank the other right hon. and hon. Members who have taken part in the debate: the right hon. Members for South Holland and The Deepings (Sir John Hayes) and for Hemel Hempstead (Sir Mike Penning); my hon. Friend the Member for Mitcham and Morden (Siobhain McDonagh); and the hon. Member for Airdrie and Shotts (Neil Gray), who spoke for the Scottish National party. It has been an excellent debate and I am definitely looking forward to hearing the Minister’s response to it.

First, like my hon. Friend the Member for Rhondda, I thank the charities working in this field, including the United Kingdom Acquired Brain Injury Forum and Headway, whose chief executive, Peter McCabe, I also have the pleasure of knowing well. I thank them all for their invaluable work to support people with acquired brain injuries and their families. I also give special thanks to Headway Wearside, which goes above and beyond for people in my region in the north-east, especially for people in my constituency. Headway Wearside has given me a lot of help over the years with constituents’ cases.

As we have heard, acquired brain injury is a leading cause of death and disability in the UK. A brain injury can happen in an instant at any age or at any stage of life, and the effect can be devastating and life-changing. ABI is a hidden epidemic, affecting many hundreds of thousands of people’s lives in many ways. As a result, and as we have heard, people with ABI face challenges that are related to more than just one Government Department. That is why I am pleased to echo my hon. Friend the Member for Rhondda and the all-party group on acquired brain injury in asking the Minister to work with her colleagues across Government Departments to ensure that people with brain injuries get the care and support they need, whatever that care and support might be.

As we have heard, every 90 seconds someone is admitted to hospital with an acquired brain injury. Thankfully, improvements in medical procedures and acute care have led to improved survival rates, which is welcome. However, as we also heard—I think it was the right hon. Member for Hemel Hempstead who made this point—that brings its own challenges and places further pressure on already stressed, indeed overstretched, health and social care services.

Early and continued access to specialist rehabilitation has been shown to optimise the chances of recovery and to be extremely cost-effective. However, there is an NHS workforce crisis, and we need more neurorehabilitation health professionals, such as physiotherapists, occupational therapists, speech and language therapists, and educational psychologists, to deliver services. What is the Government’s plan to attract prospective professionals to neuro-rehabilitation, and what are the Government doing to retain the current workforce, especially when service provision is variable across the UK?

It is crucial that people with ABI get the support they need, because this issue is also about the quality of their lives. What consideration has the Minister given to the APPG’s recommendation to establish a national review of neurorehabilitation provision? Also, rehabilitation prescriptions are very important in continuing communication and care across individual services, so will the Minister ensure that they are mandated across the services?

It is important that a patient and their family or carer know what care and support they need and what services they are currently accessing. That includes services provided by schools and other educational professionals, who may teach young children and young people with brain injuries. Best practice guidelines must be approved and followed for children and young people who return to education after an acquired brain injury, and operate throughout the rest of their education.

I will pick up on a point that my hon. Friend the Member for Rhondda made earlier, namely that if a child suffers a brain injury in their early years before they have even attended school—when they are under five—the school may never be aware of the link between their acquired brain injury and their behaviour in class, their educational ability, or indeed their behaviour in society, leading to all the issues that my hon. Friend mentioned with regard to youth offending and the need to screen prisoners, so that those who have slipped through the net throughout their school years can start to receive the help and support that they need and deserve.

All education professionals must have an awareness and understanding of ABI and the education requirements for children and young people with the condition. What conversations has the Minister had with her colleagues in the Department for Education about supporting children and young people with ABIs throughout their education? For those with pre-school ABIs—perhaps from a fall or meningitis—at the start of their education, what is being done to ensure that that information is captured and recorded in the child’s confidential record which that will follow them throughout their school years, in case issues begin to manifest themselves many years later?

What conversations has the Minister had with her colleagues in the Department for Work and Pensions about ensuring that all benefits assessors are trained to understand the problems that affect individuals with ABIs? A few hon. Members also mentioned that issue. I am talking not just about medical issues, but about how people’s behaviour or speech may be affected, as my hon. Friend the Member for Rhondda said,. Those effects may make them seem difficult to deal with, and that needs to be explained to assessors; otherwise, individuals with ABI could perhaps be harshly dealt with for something entirely outside their control. Will the Government ensure that a brain injury expert is on the consultation panel when changes in the welfare system are proposed, to ensure that the system works for people with ABI and their unique needs?

As we have heard, ABIs can be complex and therefore require attention from numerous Departments to ensure that patients and their families and carers receive the support that they need. I therefore hope that the Minister will consider everything that she has heard said in this excellent—small but perfectly formed—debate and will work in a co-ordinated and consistent way with her Government colleagues to deliver on the recommendations set out in the excellent all-party group report.

Health and Social Care

Sharon Hodgson Excerpts

Monday 3rd February 2020 Ministerial Corrections

The following is an extract from questions to the Secretary of State for Health and Social Care on 28 January 2020.

[Mrs Hodgson]

In October last year, the Government confirmed that the local authority public health grant will increase by 1% in real terms in 2020-21. However, this funding has not yet been allocated to local authorities. How will the Government financially support local authorities to establish the routine commissioning of PrEP by April?

[Jo Churchill]

As I said, NHS England and NHS Improvement have already agreed, within the ring-fenced funding for public health, to fund the ongoing costs of drugs for PrEP going forward. There will be an additional allocation of funds to cover the PrEP roll-out completely.

[Official Report, 28 January 2020, Vol. 670, c. 658.]

Letter of correction from the Under-Secretary of State for Health and Social Care, the hon. Member for Bury St Edmunds (Jo Churchill):

An error has been identified in the response I gave to the hon. Member for Washington and Sunderland West (Mrs Hodgson).

The correct response should have been:

Oral Answers to Questions

Sharon Hodgson Excerpts

Tuesday 28th January 2020 Commons Chamber

[Jo Churchill]

I assure the hon. Gentleman that NHS England and NHS Improvement have already agreed to fund all the ongoing costs of the drugs for PrEP going forward. We will provide information on how the other elements of the programme will be funded and how commissioners will be supported. He is right that the trial ends in July, but routine commissioning will be rolled out from April—we will make sure they dovetail. It is hugely important that PrEP is available for each and every person who wishes to access it.

[Mrs Sharon Hodgson (Washington and Sunderland West) (Lab)]

In October last year, the Government confirmed that the local authority public health grant will increase by 1% in real terms in 2020-21. However, this funding has not yet been allocated to local authorities. How will the Government financially support local authorities to establish the routine commissioning of PrEP by April?

[Jo Churchill]

As I said, NHS England and NHS Improvement have already agreed, within the ring-fenced funding for public health, to fund the ongoing costs of drugs for PrEP going forward. There will be an additional allocation of funds to cover the PrEP roll-out completely[Official Report, 3 February 2020, Vol. 671, c. 1MC.].

Wuhan Coronavirus

Sharon Hodgson Excerpts

Thursday 23rd January 2020 Commons Chamber

[Mrs Sharon Hodgson (Washington and Sunderland West) (Lab)]

I thank the Secretary of State for an advance copy of his statement, and for updating the House this morning.

The coronavirus is indeed very concerning, and I am grateful for the work of Public Health England and the Department on it so far, especially in screening passengers on direct flights from Wuhan. However, a passenger arriving from Wuhan yesterday said that he had gone through virtually no screening, but was given a leaflet. Does the Secretary of State have any response to that?

Will flights from other Chinese cities, not just Wuhan, be monitored, and when does the Minister think monitoring might begin? Will there be specific traveller advice for UK citizens travelling into China who have existing conditions that may mean they need to take more care?

As the Minister said, Public Health England has assessed the risk of the coronavirus being spread to the UK as “low”. In the event of the virus spreading to the UK, are there contingency plans and funds to prevent further spreading, to deal with the scale of the problem?

As the Minister knows, we are in the middle of flu season, so I do not want to cause any undue anxiety, especially as—as we have heard—there are no cases in the UK at the moment, but can he please advise people watching who may be concerned about their own symptoms of what they should do?

We all know that the NHS has a tremendous record in responding to similar incidents, such as Ebola and monkeypox. We can certainly be proud of our public health record in these areas and can be confident in how public health bodies will respond to this incident. There is a chance that a global pandemic can be avoided if Governments across the world take the right measures in a timely fashion.

I thank the Minister for his update today, and would be grateful if he could provide some further clarity on all the points I have raised.

[Matt Hancock]

I appreciate the cross-party approach that is being taken to this outbreak, as reflected in the shadow Minister’s remarks. I shall address the specific points that she raised. On the reports from the flight that arrived yesterday, it is important that we get the enhanced monitoring right. The challenge is that symptoms for the Wuhan novel coronavirus do not usually appear until five to seven days, and sometimes up to 14 days, after a person has been infected, and therefore the advice is that the most important part of the monitoring is to ensure that everybody knows what to do if the symptoms arise, because often the symptoms will not be there for somebody on the flight. Having said that, we do not expect further flights from Wuhan, because the Chinese authorities have taken steps to stop travel out of the city.

The hon. Lady asked whether we will be monitoring flights from other Chinese cities or, indeed, from anywhere else. The current evidence suggests that the vast majority of cases are in Wuhan. Obviously we keep that under constant review, and we will not hesitate to take further steps, if necessary, to protect the British public.

Surrogacy: Government Policy

Sharon Hodgson Excerpts

Tuesday 21st January 2020 Westminster Hall

[Mrs Sharon Hodgson (Washington and Sunderland West) (Lab)]

It is an honour to serve under your chairmanship, Sir David. I thank the hon. Member for Brigg and Goole (Andrew Percy) for securing this important debate and for his important work in chairing the all-party parliamentary group on surrogacy, which, as we have heard, has held evidence sessions on surrogacy law reform. I also thank him for his very warm welcome to me and the Minister in his opening remarks—it is much appreciated.

[Andrew Percy]

The hon. Lady did not welcome me back.

[Mrs Hodgson]

It is very nice to see the hon. Gentleman back in this place after the election.

I thank my hon. Friend the Member for Hornsey and Wood Green (Catherine West) and the hon. Member for East Renfrewshire (Kirsten Oswald) for their welcome, albeit short, speeches. It is definitely worthwhile in a debate such as this to have more than just one voice. I look forward to seeing the all-party parliamentary group’s report on its conclusions, and I hope to work with the group in the future.

I agree wholeheartedly with the hon. Gentleman that surrogacy is a valuable and progressive option for many people who want to have children and create a loving family. However, the key piece of legislation surrounding surrogacy is now, as he said, 35 years old and severely outdated. I know this is a problem that the Government have previously acknowledged, and I welcome the former Minister, the hon. Member for Thurrock (Jackie Doyle-Price), who did so much to move the issue forward. However, there has still not been any serious reform of surrogacy legislation and, as we have heard, problems still persist. What should be a joyous time for parents can turn into a distressing burden. Applying for parental orders can take several months, and the process fails to reflect the realities of modern-day family life.

In a survey conducted by Surrogacy UK’s working group on legal reform, 92% of respondents agreed that surrogacy law reform is needed. As we have heard, the Law Commissions are carrying out a review on surrogacy and parental orders, and it has made some primary recommendations. The hon. Gentleman went through them in detail, so I do not have to. They include a recommendation for the intended parents to become the legal parents of a child from birth as per a surrogacy agreement. I hope that the Minister will respond to some of the Law Commissions’ primary recommendations. It is due to publish its full recommendations in 2021, but will the Minister set out what steps the Government will take in the meantime to prepare a Bill that would bring surrogacy legislation into the 21st century? That would indeed be a welcome step.

The legislation needs to make the requirements for surrogacy clear and fair for everyone involved, including, and most importantly, the child. That includes a definition of what constitutes a reasonable expense. Surrogates should not make a profit, but should not be left out of pocket either. A definition would provide legal certainty to the surrogate and the intended parents.

It is crucial that children are not left in legal limbo, as my hon. Friend the Member for Hornsey and Wood Green said. With that in mind, I believe that the ability to make a parental order without the surrogate’s consent under the new regime should be applied retrospectively. That means that children who are currently in legal limbo would be lifted out of that uncertainty and would be treated equally to children born after the new regime comes into force.

It is clear that the public perception of surrogacy has moved on since 1985. It is time, therefore, that the legislation does so too. I look forward to hearing the Minister’s response.

E-cigarettes

Sharon Hodgson Excerpts

Thursday 31st October 2019 Westminster Hall

[Mrs Sharon Hodgson (Washington and Sunderland West) (Lab)]

It is a pleasure to serve under your chairmanship, Sir Henry. I apologise if I sound a bit croaky; I have a cold that is going round. Hopefully I will get rid of it soon, given what is to come over the next few weeks.

I thank the right hon. Member for North Norfolk (Norman Lamb) for introducing this debate, and for his characteristically well-informed speech. It is sad to think that it could very well be his last speech in what has been an illustrious career as an MP. I am sure that it will not be his last speech as a campaigner or activist. I also congratulate him on his work chairing the Science and Technology Committee, and on the excellent report that we are considering.

I thank all the other right hon. and hon. Members who have spoken, including the hon. Member for Ayr, Carrick and Cumnock (Bill Grant), and my right hon. Friend the Member for Rother Valley (Sir Kevin Barron), who I have enjoyed working with for many years. He has also had an illustrious career, and was an excellent Chair of the Health Committee for a number of years; he will be sorely missed in this place. There were also speeches by the hon. Member for Dartford (Gareth Johnson) and by the hon. Lady who has just spoken; I did not catch the name of her constituency.

[Sir Henry Bellingham (in the Chair)]

Brecon and Radnorshire—by-election win.

[Mrs Hodgson]

Excellent. Thank you.

As we have heard, there is still some uncertainty about the use of e-cigarettes. They entered the UK market only 12 years ago, and because this technology is still so young, we do not know for certain what its long-term impacts on health will be. What we do know is that e-cigarettes are around 95% less harmful than conventional cigarettes, and because of that, an estimated 2.9 million people in the UK are using them to stop smoking. Each year, tens of thousands of people successfully use e-cigarettes to quit. A randomised controlled trial, published in the New England Journal of Medicine earlier this year, found e-cigarettes used in a stop smoking service to be nearly twice as effective as licensed nicotine replacement therapies, such as patches and gum.

The importance of e-cigarettes as a smoking cessation tool should therefore not be dismissed. However, that must come with the caveat—I think everyone has made this point—that using an e-cigarette is not completely risk-free. There has been a recent outbreak of serious lung injury in the US linked to vaping, although that has not been replicated in the UK. Currently, 3.6 million people vape in the UK, yet the number of cases of severe respiratory pathology associated with vaping is low and diverse, with reports over a long period.

I agree with ASH’s recommendation that e-cigarette users should buy vaping products, including e-liquid, only from mainstream suppliers that sell regulated products, because using black market products may carry lethal risks. They should report any adverse effects from e-cigarettes to the Medicines and Healthcare Products Regulatory Agency using the yellow card scheme. If they experience serious adverse effects that they think are due to vaping, they should immediately stop vaping and get advice from their doctor.

Has the Minister considered launching an e-cigarette safety education programme that will ensure that e-cigarette users know the risks, and what to do if anything goes wrong and they manifest any such symptoms? That may lessen the possibility of manifesting the same patterns that we have seen in the US of lung injuries linked to e-cigarettes.

The Committee’s recommendation 4 says that NHS England should issue e-cigarette guidance to all NHS mental health trusts, and the default should be to allow e-cigarette use by patients. As we have heard, people with mental health issues smoke significantly more than the rest of the population, and could therefore benefit significantly from using e-cigarettes to stop smoking. Encouraging and allowing patients in mental health units who are smokers to switch to e-cigarettes as a means of smoking cessation would allow them to engage with their treatment sessions in the facilities without the interruption of smoking breaks.

A third of the 50 NHS trusts that responded to the Committee’s survey ban the use of e-cigarettes. The Government have agreed to issue guidance to NHS trusts about e-cigarettes. Will the Minister please tell us when she anticipates that it will be published? I know that she might have to rush it out in the next couple of days, but she might have a magic wand and be able to do that. Doing so could allow patients in mental health units to engage more fully with their treatment, which could improve outcomes.

As the Committee has found, e-cigarettes have a role to play in our society and in the Government’s commitment to achieving a smoke-free generation. However, we must ensure that advice on the safety of e-cigarettes, both short and long term, is updated regularly and publicly, so that users have the most relevant and up-to-date information available to them. The Government must also consider the role that e-cigarettes play in mental health services and improving patient outcomes across the NHS.

Every contact counts, especially when it comes to smoking cessation, and none should be missed. However, due to the Government’s public health budget cuts since 2013, which I know the Minister is not personally responsible for, smoking cessation services have suffered, leaving the most vulnerable smokers behind, without any support to quit smoking. That must change. Again, I ask the Government to reverse those public health budget cuts, so that local authorities can provide the smoking cessation services that their local communities need and deserve. I look forward to the Minister’s response.

Oral Answers to Questions

Sharon Hodgson Excerpts

Tuesday 29th October 2019 Commons Chamber

[Matt Hancock]

I wholeheartedly agree with my right hon. Friend, who is absolutely spot on about this, but there is more that we need to do in ensuring that the health inequalities of people who are homosexual or LGBT are reduced across the board. We have a whole plan to make that happen. She played an important part in government, and I will rest at nothing to ensure that we address these problems, but we should not engage in the sort of scaremongering that we have heard from the Opposition.

[Mrs Sharon Hodgson (Washington and Sunderland West) (Lab)]

I hear what the Secretary of State has said, but data from the British Association for Sexual Health and HIV have shown that nine gay and bisexual men in Greater Manchester were diagnosed with HIV while waiting to access the PrEP trial. This is likely to be just the tip of the iceberg in terms of the number of people who have acquired HIV because they could not access the trial. He will agree that this is totally unacceptable and goes against the Government’s own commitment to eradicate HIV by 2030, so does he think that PrEP should be routinely commissioned before the trial ends in September 2020 and will he commit now to that happening?

[Matt Hancock]

We are switching to routine commissioning from April. It is a deep frustration of mine that some local authorities are not putting in place the necessary measures. I will look into Manchester in particular; I did not know about that example. I personally set the goal of our being HIV-free by 2030. I am delighted that, with the support of my right hon. Friend the Member for Portsmouth North (Penny Mordaunt) when she was the Minister for Equalities, we have made the progress that we have. I have absolutely no doubt that there is further road to travel and that we should all come together in support of equalities in health provision, especially in this area. I look forward to working with the hon. Lady and all those who are on the side of trying to make this change happen.

Diabetes: Tailored Prevention Messaging

Sharon Hodgson Excerpts

Thursday 24th October 2019 Westminster Hall

[Mrs Sharon Hodgson (Washington and Sunderland West) (Lab)]

It is a pleasure to serve under your chairmanship, Ms Buck. In my long tenure as shadow Minister for Public Health, it has been a pleasure to speak in many debates with the hon. Member for Strangford (Jim Shannon), on all sorts of health issues. I congratulate him on securing this debate and on his excellent speech. I know that diabetes is an important issue to him and I thank him for speaking so honestly about his own journey with diabetes. In the past, I have spoken about my own journey, but I do not plan to dwell on that too much today.

I thank other hon. Members for their excellent contributions: my hon. Friend the Member for Heywood and Middleton (Liz McInnes), my right hon. Friend the Member for Leicester East (Keith Vaz) and the SNP spokesperson, the hon. Member for Linlithgow and East Falkirk (Martyn Day). Although there are not many of us in attendance, we have heard some excellent contributions and the debate has been full, detailed and excellent. I also thank charities such as Diabetes UK for the work that they do, both to support people with diabetes and to prevent diabetes.

Like the Secretary of State and, I am sure, the Minister, we all believe that prevention is better than cure. We all say that, and I honestly think that we all believe it. As hon. Members have said, however, the Government repeat that mantra but have cut public health funding to the tune of £700 million since 2013. Those cuts have had a serious impact on the nation’s health, but they have hit those in low-income areas the most, as we have heard. That is particularly concerning, given that children and adults living in deprived areas are substantially more likely to be obese, and obesity is a risk factor for diabetes—particularly type 2 diabetes, as my hon. Friend the Member for Heywood and Middleton made clear.

According to NHS Digital, one quarter of people living with type 2 diabetes in England are from the most deprived fifth of society, compared with 15% from the least deprived. We have had that knowledge for a long time, so it really is time that the Government used the knowledge and took action to tackle both the obesity and the diabetes epidemic, both of which disproportionately affect those in the most deprived areas.

Opposition Members have been clear that there is no silver bullet to fix the issue. However, we support the proposal to introduce a 9 pm watershed on the advertising of food that is high in fat, salt and sugar. We also support a restriction on the sale of energy drinks to under-16s and clearer labelling on food and drink—that would help us all. Those are all policies on which the Government have consulted, but we have yet to see anything from the Government setting out whether they will be implemented. Can the Minister update us on the consultations when she responds?

[Jim Shannon]

I congratulate the hon. Lady on her contribution and her comments. I was sitting here thinking about families and diabetes. In a family of four or five, there may be one diabetic member of the household. I believe that the whole family—mum and dad, brothers and sisters; whoever it may be—need to give consideration to the person with diabetes to ensure that their battle with diabetes is one that the whole family fights together. That is difficult to do, but it is important that families realise that they have a job to do.

[Mrs Hodgson]

I am not sure whether there is a hereditary aspect to it, but I am aware that sometimes there can be a number of people with diabetes in the same family. I am the only one I know of in my family with the condition, but then again I do not know my father’s side. My mam always says that I take after my dad with regard to my size, so perhaps there is a link and I am just not aware of it. The eating habits of members of a family can be very similar. If eating habits have led someone to get diabetes, the condition could have affected others in the same family, so the hon. Gentleman makes a valid point.

The evidence shows that the policies proposed by the Government, if they are fully and quickly implemented, could help us to make real progress towards reducing childhood obesity by 2030. Will the Minister tell us what the delay is? Instead of just window-dressing with the childhood obesity plan chapters 1 and 2 and the former chief medical officer’s special report on childhood obesity, which we had in the past couple of weeks, the Government must now take bold action and implement all the policies in the reports. The time for reports and consultations is over. We all know what needs to be done, and now we need urgent action.

According to NHS England, managing the growing incidence of diabetes in England is set to become one of the major clinical challenges of the 21st century, as we have heard expressed clearly in this debate. Estimates suggest that the number of people with diabetes is expected to rise to 4.2 million by 2030, affecting almost 9% of the population, with all the associated costs.

More than half of all cases of type 2 diabetes could be prevented or delayed. The hon. Member for Strangford and my right hon. Friend the Member for Leicester East both spoke about that in detail. By reducing the number of people who are overweight or obese, we can reduce the number of people who develop type 2 diabetes and live with the life-changing complications that are associated with it. Like the hon. Gentleman, I wish I had known much sooner the irreversible damage that I was doing to myself. I have done a detailed blog post about it, which is available online, if anyone is interested in my thoughts—I will go into them no further in this debate. Steps that the Government take today will benefit people greatly tomorrow, so will the Minister please outline the Government’s plans to prevent further incidence of diabetes?

There is no one-size-fits-all approach to diabetes, which is why targeted messaging and support is so important, alongside societal and environmental changes to tackle obesity, as I have mentioned. Interventions such as NHS health checks, weight management programmes and the NHS diabetes prevention programme should therefore be offered and taken up more often in order to identify risk and to prevent diabetes. Many people who are eligible for the NHS health checks are not invited to them or do not attend.

What will the Government do to encourage people to attend their NHS health check and to ensure that everyone who is eligible is definitely invited for a check? About 1 million people live with undiagnosed type 2 diabetes, and one in three people already have diabetes complications by the time they are diagnosed with type 2 diabetes, so that service could be invaluable in preventing further incidence of diabetes and of the complications that sufferers experience.

Those who have diabetes know that it is possible to put type 2 diabetes into remission through substantial weight loss. As the hon. Member for Strangford mentioned, my hon. Friend the Member for West Bromwich East (Tom Watson) has been incredibly vocal about his very visible journey. He has been an inspiration to many. We need to make sure that when people go into diabetes remission, they continue to get support, access to diabetes monitoring and, where necessary, care, because, as I was told, “You are never cured.” Even if someone with diabetes is in remission through diet, they will still forever be a diabetic—we have broken our bodies, basically.

People who wish to go into remission must have continued support. There is still a need for more research to understand the long-term impact of remission on reducing complications, but for now the future in that regard looks positive. This debate has been excellent, and it has demonstrated that there are clearly steps that the Government can and should take to prevent diabetes. I hope that the Minister will take them on board. I look forward to her response.

In closing, I thank and congratulate—on behalf of all us who are living with diabetes—Professor Ian Shanks, the inventor of the blood glucose monitor some 40 years ago. I was so pleased to hear the news overnight that he is to be paid a small award. I say “small” because, although it is £2 million, I understand that most of it will be eaten up by the legal costs of a 13-year battle. He might not be a rich man after he has paid all his legal bills, but he will be rich in terms of gratitude for the millions of lives he has saved, and no doubt improved, with his invention.

Specific Food Hygiene (Regulation (EC) No. 853/2004) (Amendment) (EU Exit) Regulations 2019

Sharon Hodgson Excerpts

Monday 7th October 2019 General Committees

[Mrs Sharon Hodgson (Washington and Sunderland West) (Lab)]

I am grateful, Dame Cheryl; I was not sure what order we would speak in. It has been a while since I have done one of these Delegated Legislation Committees; it was probably before the summer recess, when we did quite a few. I am very pleased to serve under your chairmanship, Dame Cheryl, and I thank the Minister for introducing the statutory instrument and providing a summary of it.

As the Minister said, the SI was discussed earlier this year by the hon. Member for Winchester (Steve Brine), and a lot has changed. We have had not just our summer holidays, but a full remake of the Government—we have a totally new Government. Nevertheless, we still have uncertainty about whether the UK will leave the EU in 24 days, with or without a deal, and about the impact that could have. As legislators, we have to get this right, and I deeply regret that once again we find ourselves back in this room debating necessary SIs and having to rush this legislation through in case of a no-deal Brexit, which none of us in the Opposition wants. I know some Members on the Government side do not want it either.

I move on to the legislation before us. As we all agree, the safety of our food is of the utmost importance to our health and wellbeing, and we cannot get it wrong. Food safety must be protected at all costs. I share the Government’s commitment to ensuring that there is no change in the high-level principles underpinning the day-to-day functioning of the food safety legal framework. Ensuring continuity for business and public health bodies is of the utmost importance and in the interest of the public.

The Minister will not be surprised that I have a few questions about the SI. First, why was this missed from the SI in March? She might have touched on that. Has any assessment been made of what would have happened had the UK left the EU in March without a deal and without the SI in place? What exactly will the Minister’s responsibilities be under the SI? Finally, what additional substances can be approved by Ministers if needed, and how will that impact food safety? I see that the SI gives some leeway for Ministers to approve substances that can be added to our food. I would be interested to hear how confident the Minister is that a high standard for food safety will be maintained from day one of Britain’s exit from the EU.

The safety of our food is hugely important, and we cannot get this wrong. With those few brief comments, and not wanting to delay the Committee, I look forward to the Minister’s response.

[The Chair]

We do have one and a half hours for this debate, if people wish to take it. I call the hon. Member for Paisley and Renfrewshire North, who speaks for the Scottish National party.